7th February 2017

Sports Integrity Briefs – 7 February 2017

• Football (38%) and tennis (37%) topped the suspicious alerts reported to the Sports Betting Intelligence Unit (SBIU) of Great Britain’s Gambling Commission from October to December 2016, figures published today reveal. The majority (82%) of the alerts reported to the SBIU came from betting operators. The Gambling Commission said that details on the exact numbers of alerts reported to the SBIU must remain confidential due to the risk of jeopardising ongoing investigations.

• The US Anti-Doping Agency (USADA) has issued information regarding ostarine, a selective androgen receptor modulator (SARM) that is not approved for human use, after two triathletes were sanctioned after returning adverse analytical findings (AAFs) for the substance. Both athletes argued that they had not intentionally consumed ostarine, and presented evidence that their AAF may have been the result of contaminated salt tablets or supplements.

• The European Canoe Association (ECA) has announced the minimum number of anti-doping samples that must be taken from athletes at events that it sanctions during 2017. At Sprint events, 38 samples must be taken, comprising 16 from seniors; eight from both U23 and junior athletes, plus six from paracanoeing. At Slalom events, a minimum of 24 samples must be taken, comprising 12 from senior athletes and six from both U23 and junior athletes. At Wild Water events, nine samples must be taken: six from seniors and three from juniors. At Marathon events, 12 samples must be taken and at Canoe Polo events, six samples must be taken. At Freestyle events, four samples must be taken (two from both seniors and juniors). At Dragonboat events, six samples must be taken and at Ocean Canoeing events, four samples must be taken. The ECA said that the number of samples taken at events can be increased at the request of the International Canoe Federation (ICF) for events such as Olympic qualifiers.

• Ultimate Fighting Championship (UFC) athlete Daniel Omielanczuk has accepted a finding of no fault for an adverse analytical finding (AAF) for meldonium in July last year, and will not serve a period of ineligibility. ‘Omielanczuk presented evidence establishing that his use of meldonium was limited to a three-week span, from mid-August to early September 2015’, read a statement. ‘Omielanczuk and his advisors confirmed that Omielanczuk did not resume his use of the substance after September 2015 because they became aware that the substance would be added to the WADA Prohibited List in 2016, and subsequently banned under the UFC Anti-Doping Program’. Yesterday, it emerged that Girmay Birahun, a 22-year-old Ethiopian athlete, faces a minimum of three years in jail after testing positive for meldonium.

You may also like...

Pin It on Pinterest

Share This